PURPOSE: To describe the clinical features of children with anophthalmos, microphthalmos, and typical coloboma (AMC). DESIGN: Descriptive, observational, cross-sectional study of the United Kingdom. PARTICIPANTS: A total of 135 children with AMC newly diagnosed over an 18-month period beginning in October 2006. METHODS: Cases were identified using active surveillance through an established ophthalmic surveillance system. Eligible cases were followed up 6 months after first notification. MAIN OUTCOME MEASURES: Phenotypic characteristics, both ocular and systemic, clinical investigations, causes, and interventions. RESULTS: A total of 210 eyes (of 135 children) were affected by AMC, of which 153 had isolated coloboma or coloboma with microphthalmos. The most common colobomatous anomaly was a chorioretinal defect present in 109 eyes (71.2%). Some 44% of children were bilaterally visually impaired. Systemic abnormalities were present in 59.7% of children, with craniofacial anomalies being the most common. Children with bilateral disease had a 2.7 times higher odds (95% confidence interval, 1.3-5.5, P = 0.006) of having systemic involvement than unilaterally affected children. Neurologic imaging was the most frequent investigation (58.5%) performed. Less than one third (30.3%) of the children with microphthalmos had ocular axial lengths measured. Eight children had confirmed genetic mutations. Approximately half (49.2%) of the children required ocular intervention. CONCLUSIONS: Colobomatous defects were the most common phenotype within this spectrum of anomalies in the United Kingdom. The high frequency of posterior segment colobomatous involvement means that a dilated fundal examination should be made in all cases. The significant visual and systemic morbidity in affected children underlines the importance of a multidisciplinary approach to management.
PURPOSE: To describe the clinical features of children with anophthalmos, microphthalmos, and typical coloboma (AMC). DESIGN: Descriptive, observational, cross-sectional study of the United Kingdom. PARTICIPANTS: A total of 135 children with AMC newly diagnosed over an 18-month period beginning in October 2006. METHODS: Cases were identified using active surveillance through an established ophthalmic surveillance system. Eligible cases were followed up 6 months after first notification. MAIN OUTCOME MEASURES: Phenotypic characteristics, both ocular and systemic, clinical investigations, causes, and interventions. RESULTS: A total of 210 eyes (of 135 children) were affected by AMC, of which 153 had isolated coloboma or coloboma with microphthalmos. The most common colobomatous anomaly was a chorioretinal defect present in 109 eyes (71.2%). Some 44% of children were bilaterally visually impaired. Systemic abnormalities were present in 59.7% of children, with craniofacial anomalies being the most common. Children with bilateral disease had a 2.7 times higher odds (95% confidence interval, 1.3-5.5, P = 0.006) of having systemic involvement than unilaterally affected children. Neurologic imaging was the most frequent investigation (58.5%) performed. Less than one third (30.3%) of the children with microphthalmos had ocular axial lengths measured. Eight children had confirmed genetic mutations. Approximately half (49.2%) of the children required ocular intervention. CONCLUSIONS: Colobomatous defects were the most common phenotype within this spectrum of anomalies in the United Kingdom. The high frequency of posterior segment colobomatous involvement means that a dilated fundal examination should be made in all cases. The significant visual and systemic morbidity in affected children underlines the importance of a multidisciplinary approach to management.
Authors: Vincent D Venincasa; Yasha S Modi; Hassan A Aziz; Bernadette Ayres; Claus Zehetner; Wei Shi; Timothy G Murray; Harry W Flynn; Audina M Berrocal Journal: Invest Ophthalmol Vis Sci Date: 2015-06 Impact factor: 4.799
Authors: Nancy Huynh; Delphine Blain; Tanya Glaser; E Lauren Doss; Wadih M Zein; David M Lang; Eva H Baker; Suvimol Hill; Carmen C Brewer; Jeffrey B Kopp; Tanya M Bardakjian; Irene H Maumenee; Bronwyn J Bateman; Brian P Brooks Journal: Am J Ophthalmol Date: 2013-09-05 Impact factor: 5.258
Authors: Sabrina C Fox; Sonya A Widen; Mika Asai-Coakwell; Serhiy Havrylov; Matthew Benson; Lisa B Prichard; Pranidhi Baddam; Daniel Graf; Ordan J Lehmann; Andrew J Waskiewicz Journal: Hum Genet Date: 2022-01-28 Impact factor: 5.881
Authors: Daniel Kelberman; Lily Islam; Jörn Lakowski; Chiara Bacchelli; Estelle Chanudet; Francesco Lescai; Aara Patel; Elia Stupka; Anja Buck; Stephan Wolf; Philip L Beales; Thomas S Jacques; Maria Bitner-Glindzicz; Alki Liasis; Ordan J Lehmann; Jürgen Kohlhase; Ken K Nischal; Jane C Sowden Journal: Hum Mol Genet Date: 2014-01-09 Impact factor: 6.150
Authors: Christina Gerth-Kahlert; Kathleen Williamson; Morad Ansari; Jacqueline K Rainger; Volker Hingst; Theodor Zimmermann; Stefani Tech; Rudolf F Guthoff; Veronica van Heyningen; David R Fitzpatrick Journal: Mol Genet Genomic Med Date: 2013-03-27 Impact factor: 2.183